Review




Structured Review

Dexcom Inc rt-cgm dexcom g5 mobile
Rt Cgm Dexcom G5 Mobile, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/dexcom+g6/pm33322931-33-26-29
Average 90 stars, based on 1 article reviews
rt-cgm dexcom g5 mobile - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Control:

Article Title: The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials
Article Snippet: Heinemann et al. HypoDE , 149 adults (MDI) , RT-CGM (Dexcom G5 Mobile) ( n = 75) , SMBG ( n = 74) , 6 , No difference , 70–180 mg/dl (3.9–10.0 mmol/l) Median (baseline to follow-up) RT-CGM 57.8–58.5% = 13.9–14.0 h/day SMBG 59.1–56.5% = 14.2–13.6 h/day Adjusted between-group difference 3.1 (0.0–6.2)% = 0.75 (0.0–1.5) h/day , <70 mg/dl (3.9 mmol/l) Median (baseline to follow-up) RT-CGM 5.0–1.6% = 1.2–0.4 h/day SMBG 6.9–6.4% = 1.7–1.5 h/day <54 mg/dl (3.0 mmol/l) Median (baseline to follow-up) RT-CGM 1.7–0.3% = 0.4–0.1 h/day SMBG 2.7–2.5% = 0.65 to 0.6 h/day , ↓ Hypo distress ↑ Satisfaction.

Article Title: Impact of Real-Time CGM Data Sharing on Quality of Life in the Caregivers of Adults and Children With Type 1 Diabetes
Article Snippet: Inclusion criteria for spouses/partners were similar: age ≥25 years, and in an ongoing relationship ≥12 months with a spouse/partner with T1D ≥12 months, who was currently using the Dexcom RT-CGM (either the Dexcom G5 Mobile or Dexcom G6 Systems), and had been sharing with the spouse/partner respondent >3 months.

Article Title: Impact of Real-Time CGM Data Sharing on Quality of Life in the Caregivers of Adults and Children With Type 1 Diabetes.
Article Snippet: Background: To examine caregivers’ experiences with real-time continuous glucose monitoring (RT-CGM) data sharing and its impact on quality of life (QoL) and health outcomes.. Methods: Parents of children with type 1 diabetes (T1D) (N = 303) and spouses/partners of T1D adults (N = 212) using the Dexcom G5 Mobile or G6 RT-CGM system and who were actively following their T1Ds’ RT-CGM data completed a survey examining their perceived value of data sharing, the impact of sharing on their own QoL and their child/partner’s health, and how they used RT-CGM data to support their T1Ds’ diabetes management.. Regression analyses examined whether their actions were linked to reported changes in QoL and health outcomes.

Article Title: Practical Approach to Using Trend Arrows on Real-Time Continuous Glucose Monitoring System in Type 1 Diabetes Adolescents Living Camp Setting Treated With Multiple Daily Injection or Continuous Subcutaneous Insulin Infusion Insulin Therapy
Article Snippet: We developed and applied a new protocol for therapy management based on rt-CGM Dexcom G5 Mobile information in a camp setting with a group of T1D teenagers.

Article Title: The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials
Article Snippet: Burckhardt et al. , 49 Children & their Parents (20 MDI; 29 CSII) , RT-CGM (Dexcom G5 Mobile) ( n = 48) , SMBG ( n = 48) , 2 × 3 (cross-over) , No difference , NI , NI , ↓ Hypo fear ↓ Family impact ↓ Stress ↑ Improvement of psychosocial metrics ↑ Satisfaction .

Injection:

Article Title: The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials
Article Snippet: Heinemann et al. HypoDE , 149 adults (MDI) , RT-CGM (Dexcom G5 Mobile) ( n = 75) , SMBG ( n = 74) , 6 , No difference , 70–180 mg/dl (3.9–10.0 mmol/l) Median (baseline to follow-up) RT-CGM 57.8–58.5% = 13.9–14.0 h/day SMBG 59.1–56.5% = 14.2–13.6 h/day Adjusted between-group difference 3.1 (0.0–6.2)% = 0.75 (0.0–1.5) h/day , <70 mg/dl (3.9 mmol/l) Median (baseline to follow-up) RT-CGM 5.0–1.6% = 1.2–0.4 h/day SMBG 6.9–6.4% = 1.7–1.5 h/day <54 mg/dl (3.0 mmol/l) Median (baseline to follow-up) RT-CGM 1.7–0.3% = 0.4–0.1 h/day SMBG 2.7–2.5% = 0.65 to 0.6 h/day , ↓ Hypo distress ↑ Satisfaction.

Article Title: Impact of Real-Time CGM Data Sharing on Quality of Life in the Caregivers of Adults and Children With Type 1 Diabetes
Article Snippet: Inclusion criteria for spouses/partners were similar: age ≥25 years, and in an ongoing relationship ≥12 months with a spouse/partner with T1D ≥12 months, who was currently using the Dexcom RT-CGM (either the Dexcom G5 Mobile or Dexcom G6 Systems), and had been sharing with the spouse/partner respondent >3 months.

Article Title: Impact of Real-Time CGM Data Sharing on Quality of Life in the Caregivers of Adults and Children With Type 1 Diabetes.
Article Snippet: Background: To examine caregivers’ experiences with real-time continuous glucose monitoring (RT-CGM) data sharing and its impact on quality of life (QoL) and health outcomes.. Methods: Parents of children with type 1 diabetes (T1D) (N = 303) and spouses/partners of T1D adults (N = 212) using the Dexcom G5 Mobile or G6 RT-CGM system and who were actively following their T1Ds’ RT-CGM data completed a survey examining their perceived value of data sharing, the impact of sharing on their own QoL and their child/partner’s health, and how they used RT-CGM data to support their T1Ds’ diabetes management.. Regression analyses examined whether their actions were linked to reported changes in QoL and health outcomes.

Article Title: Practical Approach to Using Trend Arrows on Real-Time Continuous Glucose Monitoring System in Type 1 Diabetes Adolescents Living Camp Setting Treated With Multiple Daily Injection or Continuous Subcutaneous Insulin Infusion Insulin Therapy
Article Snippet: We developed and applied a new protocol for therapy management based on rt-CGM Dexcom G5 Mobile information in a camp setting with a group of T1D teenagers.

Article Title: The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials
Article Snippet: Burckhardt et al. , 49 Children & their Parents (20 MDI; 29 CSII) , RT-CGM (Dexcom G5 Mobile) ( n = 48) , SMBG ( n = 48) , 2 × 3 (cross-over) , No difference , NI , NI , ↓ Hypo fear ↓ Family impact ↓ Stress ↑ Improvement of psychosocial metrics ↑ Satisfaction .



Similar Products

90
Dexcom Inc rt-cgm dexcom g5 mobile
Rt Cgm Dexcom G5 Mobile, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g5+mobile/dexcom+g6/pm33322931-33-26-29
Average 90 stars, based on 1 article reviews
rt-cgm dexcom g5 mobile - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results